Company / Operating Income
TREACE MEDICAL CONCEPTS, INC. Operating Income History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$51.4M
FY2025
5-year range
-$51.4M / $855.0K
FY2021-FY2025
Trend
-47.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income has declined for 3 consecutive years, from $855,000 in FY2022 to -$51M in FY2025.
Based on SEC 10-K filings.
-$51M in FY2025.
Declined from -$17M to -$51M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- TREACE MEDICAL CONCEPTS, INC.'s operating income has declined for 3 consecutive years.
- In FY2025, operating income decreased 47.6% year-over-year.
- Peak operating income was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 1.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$51.4M | -47.6% |
| FY2024 | -$34.8M | -111.0% |
| FY2023 | -$16.5M | -2031.0% |
| FY2022 | $855.0K | +124.2% |
| FY2021 | -$3.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026